Jan 21, 2026 06:00PM Onco-Innovations Engages i2i Marketing Group Engagement for Market Awareness Services

Dec 9, 2025 06:00PM Onco-Innovations Chairs Colorectal Cancer Canada Precision Oncology Forum Generating Roadmaps for the Next Era of Cancer Care

Dec 7, 2025 03:00AM Onco-Innovations Engages Investment Bank to Pursue Nasdaq Cross-listing and Potential Concurrent Equity Offering

Nov 25, 2025 04:30PM Onco-Innovations Attends University of Alberta's 2025 Innovation Awards

Nov 20, 2025 07:30PM Onco-Innovations begins scale-up work for cancer drug with Dalton Pharma

Nov 20, 2025 07:30PM Onco-Innovations Advances Optimization and Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services to Support Future Phase 1 Clinical Studies

Nov 18, 2025 06:00PM Onco-Innovations Advances AI and Quantum Drug Discovery with Kuano Collaboration to Accelerate PNKP Inhibitor Technology Development

Nov 7, 2025 06:00PM Onco-Innovations' Inka Health Publishes Framework on Transportability of Real-World Evidence and Use in Health Technology Assessment

Oct 31, 2025 06:00PM Onco-Innovations Provides Shareholder Update Following Cboe Canada Investor Spotlight

Oct 30, 2025 09:00PM Onco-Innovations appoints Jared Rushton to board of directors

Oct 30, 2025 09:00PM Onco-Innovations Appoints Jared Rushton to Board of Directors

Oct 27, 2025 05:15PM Onco-Innovations closes $2 million private placement

Oct 27, 2025 05:15PM Onco-Innovations Announces Closing of Private Placement

Oct 14, 2025 08:00PM Onco-Innovations plans $2 million private placement offering

Oct 14, 2025 08:00PM Onco-Innovations Announces Private Placement

Sep 29, 2025 12:00AM Onco-Innovations Advances Preclinical Program as Nucro-Technics Begins Analytical Development for PNKP Technology

Sep 22, 2025 05:00PM AMN Healthcare prices $400 million senior notes offering

Sep 22, 2025 05:00PM Onco-Innovations Appoints Dr. Michael Lock to Scientific & Clinical Advisory Board

Sep 19, 2025 06:00PM Onco-Innovations Commences Activities to Manufacture Nanoparticle Formulation with Dalton Pharma to Supply Preclinical Animal Studies

Sep 12, 2025 06:00PM Onco-Innovations to Chair Colorectal Cancer Canada Precision Oncology Forum Driving the Future of Cancer Care

Aug 15, 2025 09:15AM Onco-Innovations Announces 90% of $0.60 Warrants Have Been Exercised

Aug 13, 2025 05:01PM Onco-Innovations closes $400,000 private placement

Aug 13, 2025 05:00PM Onco-Innovations Announces Closing of Private Placement

Aug 4, 2025 04:05PM Onco-Innovations Advances Progress Towards First-in-Human Trial with Avance Clinical Start-Up Agreement

Jul 30, 2025 06:00PM Inka Health Selected by OneMedNet to Lead AI-Driven Oncology Project Using Real-World Data for External Control Arms

Jul 29, 2025 09:30PM Onco-Innovations plans $400,000 private placement and stock grants

Jul 29, 2025 09:30PM Onco-Innovations Announces Private Placement

Jul 11, 2025 06:00PM Onco-Innovations Signs Agreement with Redwood AI to Advance Discovery and Evaluation of Its PNKP Inhibitor Technology

Jul 4, 2025 06:00PM Onco-Innovations Enters Agreement with Nucro-Technics for IND-Enabling Studies, Taking a Key Step Toward Human Trials

Jul 2, 2025 06:30PM Onco-Innovations CEO Highlights Strategic Milestones and R&D Progress in Special Investors' Conference Call

Jun 25, 2025 06:00PM Onco-Innovations' CEO to Host Special Investors' Conference Call on Wednesday, July 2, 2025

Jun 20, 2025 06:00PM Inka Health Co-Founders Publish New Study Advancing Real-World Applicability of Lung Cancer Clinical Trial Outcomes

May 26, 2025 09:00AM Onco-Innovations Extends Marketing Program

May 22, 2025 06:00PM Onco-Innovations Announces Appointment of Professor Steven Jones as Senior Scientific Advisor, Strengthening Technical Acumen in AI-Powered Precision Oncology

Apr 24, 2025 06:00PM Onco-Innovations' Inka Health Signs New Analytical Work with AstraZeneca Canada to Advance Real-World Evidence in Regulatory Science

Apr 17, 2025 06:00PM Onco-Innovations Announces Partnership with Dalton Pharma for Isotope Synthesis of Patented PNKP Technology

Apr 16, 2025 07:30PM Onco-Innovations Announces Private Placement

Apr 10, 2025 06:00PM Onco-Innovations’ Inka Health Publishes Roche-Sponsored Study Advancing Real-World Oncology Research

Apr 3, 2025 06:00PM Onco-Innovations' Inka Health Completes Analytical Work for AstraZeneca Canada, Advancing Pharmaceutical Analytics and Leading to Key Studies at ISPOR 2025

Mar 26, 2025 06:00PM Onco-Innovations' PKNP Technology Used with Radiation Therapy Shown in Study to Demonstrate Low Toxicity and High Safety Profile

Mar 25, 2025 05:00PM Onco-Innovations Extends Marketing Program

Mar 24, 2025 06:00PM Onco-Innovations Provides Update on Use of Proceeds

Mar 2, 2025 03:00PM Onco-Innovations CEO Thomas O’Shaughnessy Featured on Conversations That Matter to Discuss Breakthroughs in Cancer Treatment, AI Integration, and Potential Global Expansion

Feb 27, 2025 06:00PM Onco-Innovations' Inka Health Innovative AI-Driven Oncology Study Paves the Way for New Research

Feb 24, 2025 06:00PM Onco-Innovations' PKNP Technology Shown in Study to Demonstrate Low Toxicity and High Safety Profile

Feb 21, 2025 06:05PM Onco-Innovations Provides Information Regarding Inka Health's USPTO Provisional Patent Application for AI-Powered Precision Medicine Platform, SynoGraph

Feb 21, 2025 12:10AM Onco-Innovations Announces U.S. Listing on the OTCQB Market